Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE2131.657.15 (+0.34 %)
PREV CLOSE () 2124.50
OPEN PRICE () 2124.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 135165
TODAY'S LOW / HIGH ()2111.75 2140.25
52 WK LOW / HIGH ()1303 2134.95
NSE2131.405.3 (+0.25 %)
PREV CLOSE() 2126.10
OPEN PRICE () 2129.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2131.40 (24)
VOLUME 394549
TODAY'S LOW / HIGH() 2107.70 2141.00
52 WK LOW / HIGH ()1385.75 2135
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1976

Management Info :

Arun Duggal - Chairman - Managing Director

Registered Office :

Address : Neelam Centre, ' B 'wing,4th Floor, Hind Cycle Road,Worli,
Mumbai,
Maharashtra-400030

Phone : 022- 2482 2222

Website : www.jbpharma.com

Registrar's Details : Datamatics Business Solutions Ltd.
Plot No. A 16 & 17,Part B Cross Lane,MIDC, Andheri (E),Mumbai
Listing : BSE, NSE
NEWS
23Feb JB Chemicals & Pharmaceuticals informs
With refer to letter dated February 20, 2026, in relation to submission..
21Feb J.B. Chemicals & Pharmaceuticals infor
J.B. Chemicals & Pharmaceuticals has informed that it enclosed the P..
22Jan JB Chemicals & Pharmaceuticals inform
JB Chemicals & Pharmaceuticals has informed that the exchange has re..
22Jan JB Chemicals & Pharmaceuticals informs
JB Chemicals & Pharmaceuticals has informed that the exchange has re..
21Jan JB Chemicals & Pharmaceuticals informs
Pursuant to Regulation 30 read with Schedule III of the Listing Regulati..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit1792.76525.4
Gross Profit 2411.8 8771.1
Operating Profit 2863.910526.8
Net Sales 9909.137229.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
RPG Life Sciences (BSE)
 1970.30 (4.30%)
M.Cap ( in Cr)
3258.68
Ajanta Pharma (BSE)
 3122.15 (2.52%)
M.Cap ( in Cr)
39006.78
Venus Remedies (BSE)
 927.50 (7.46%)
M.Cap ( in Cr)
1239.79
Ipca Laboratories (BSE)
 1559.55 (1.79%)
M.Cap ( in Cr)
39566.44
Jubilant Pharmova (BSE)
 830.55 (2.68%)
M.Cap ( in Cr)
13229.09
Shareholding Pattern
PROMOTERS 47.55%
MUTUAL FUNDS/UTI 19.61%
NON-INSTITUTION 14.22%
FI/BANKS/INSURANCE 2.16%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76034.42-829.29 (-1.08%)
NIFTY23639.15-227.70 (-0.95%)
Dow Jones 47417.27-289.24 (-0.61%)
Nasdaq 22716.1319.04 (0.08%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI